G1 THERAPEUTICS, INC. Lease, Cost
G1 THERAPEUTICS, INC. reported Lease, Cost of $1.55 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2024-02-28
- G1 THERAPEUTICS, INC. lease, cost for the quarter ending 2019-12-31 was $503.00K, a 329.91% increase year-over-year.
- G1 THERAPEUTICS, INC. lease, cost for the quarter ending 2019-09-30 was $245.00K, a 142.57% increase year-over-year.
- G1 THERAPEUTICS, INC. lease, cost for the quarter ending 2019-06-30 was $115.00K, a 27.78% increase year-over-year.
- G1 THERAPEUTICS, INC. lease, cost for the quarter ending 2019-03-31 was $114.00K, a 56.16% increase year-over-year.
- G1 THERAPEUTICS, INC. lease, cost for fiscal 2023 was $1.55M, a 6.72% decline from fiscal 2022.
- G1 THERAPEUTICS, INC. lease, cost for fiscal 2022 was $1.67M, a 0.18% decline from fiscal 2021.
- G1 THERAPEUTICS, INC. lease, cost for fiscal 2021 was $1.67M, a 22.23% decline from fiscal 2020.
- G1 THERAPEUTICS, INC. lease, cost for fiscal 2020 was $2.15M, a 119.65% increase from fiscal 2019.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.55M 10-K · filed 2024-02-28 | |||
| 2022-12-31 | $1.67M 10-K · filed 2024-02-28 | |||
| 2021-12-31 | $1.67M 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $2.15M 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $748.00K derived: sum of 2 quarters · filed 2022-02-23 | $863.00K derived: sum of 3 quarters · filed 2022-02-23 | $977.00K 10-K · filed 2022-02-23 |
| 2019-09-30 | $245.00K 10-Q · filed 2019-11-05 | $360.00K derived: sum of 2 quarters · filed 2019-11-05 | $474.00K 10-Q · filed 2019-11-05 | $591.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $115.00K 10-Q · filed 2019-08-07 | $229.00K 10-Q · filed 2019-08-07 | $346.00K derived: sum of 3 quarters · filed 2021-02-24 | $447.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $114.00K 10-Q · filed 2019-05-09 | $231.00K derived: sum of 2 quarters · filed 2021-02-24 | $332.00K derived: sum of 3 quarters · filed 2021-02-24 | $422.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $218.00K derived: sum of 2 quarters · filed 2021-02-24 | $308.00K derived: sum of 3 quarters · filed 2021-02-24 | $381.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | $101.00K 10-Q · filed 2019-11-05 | $191.00K derived: sum of 2 quarters · filed 2019-11-05 | $264.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $90.00K 10-Q · filed 2019-08-07 | $163.00K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $73.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $252.00K 10-K · filed 2020-02-26 |